Compare WTS & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WTS | GKOS |
|---|---|---|
| Founded | 1874 | 1998 |
| Country | United States | United States |
| Employees | 5700 | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 10.6B |
| IPO Year | 1994 | 2015 |
| Metric | WTS | GKOS |
|---|---|---|
| Price | $358.05 | $157.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 12 |
| Target Price | ★ $335.00 | $126.92 |
| AVG Volume (30 Days) | 152.5K | ★ 681.0K |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.70% | N/A |
| EPS Growth | ★ 17.03 | N/A |
| EPS | ★ 6.50 | N/A |
| Revenue | ★ $2,438,500,000.00 | $507,442,000.00 |
| Revenue This Year | $11.17 | $23.32 |
| Revenue Next Year | $5.72 | $27.43 |
| P/E Ratio | $55.08 | ★ N/A |
| Revenue Growth | 8.27 | ★ 32.33 |
| 52 Week Low | $260.00 | $73.16 |
| 52 Week High | $394.54 | $191.62 |
| Indicator | WTS | GKOS |
|---|---|---|
| Relative Strength Index (RSI) | 50.57 | 38.02 |
| Support Level | $335.78 | $145.78 |
| Resistance Level | $359.12 | $161.53 |
| Average True Range (ATR) | 5.93 | 6.97 |
| MACD | 0.89 | -1.42 |
| Stochastic Oscillator | 79.61 | 22.78 |
Watts Water Technologies Inc is a U.S.-based company that provides safety, energy efficiency, and water conservation products. Its product portfolio includes residential and commercial flow control products, which are sold for plumbing and hot water applications; HVAC and gas products, including commercial boilers, water heaters, heating solutions, etc.; drainage and water reuse products, including drainage products and engineered rainwater-harvesting solutions; and water quality products, including point-of-use and point-of-entry water filtration, conditioning, and scale prevention systems. Its products are marketed through brands like Watts, Apex, Bradley, Nexa, and others. Geographically, the company derives its key revenue from the Americas, followed by Europe and the APMEA region.
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.